Antineoplastics

Customized

Antineoplastics

Antineoplastic APIs include cytotoxic drugs, targeted inhibitors, antimetabolites, alkylating agents, and immune-modulating anticancer compounds. They are used for treating solid tumors, hematologic malignancies, metastatic cancers, and precancerous conditions. These APIs require extremely strict purity control, impurity profiling, and stability testing due to their high potency and clinical sensitivity.

Naturally Derived Antineoplastic Agents

Naturally derived antineoplastic agents include APIs sourced from plants, microorganisms, and marine organisms, offering potent cytotoxic or targeted anticancer properties. Major classes include vinca alkaloids, taxanes, camptothecin derivatives, epipodophyllotoxins, and marine-derived cytotoxins. These agents act through mechanisms such as microtubule stabilization or inhibition, topoisomerase I and II inhibition, or disruption of mitochondrial pathways. They are widely used to treat leukemias, lymphomas, breast cancer, ovarian cancer, and various solid tumors. Their structural complexity provides unique therapeutic advantages but often requires specialized formulation to manage solubility and toxicity. Naturally derived anticancer APIs remain essential components of combination regimens and continue to inspire novel semi-synthetic and synthetic anticancer molecules.

10-Deacetylbaccatin Iii CAS NO 32981-86-5

Unit Price:Get Price

CAS No.:32981-86-5

Grade:Pharmacy Grade

Content:99.00%

Packaging:Customizable

Etoposide CAS NO 33419-42-0

Unit Price:Get Price

CAS No.:33419-42-0

Grade:Pharmacy Grade

Content:99.00%

Packaging:Customizable

Asparaginase CAS NO 9015-68-3

Unit Price:Get Price

CAS No.:9015-68-3

Grade:Pharmacy Grade

Content:99.00%

Packaging:Customizable

Vinblastinesulfateusp28 CAS NO 143-67-5

Unit Price:Get Price

CAS No.:143-67-5

Grade:Pharmacy Grade

Content:99.0%

Packaging:Customizable

Vinblastine Sulfate CAS NO 143-67-9

Unit Price:Get Price

CAS No.:143-67-9

Grade:Pharmacy Grade

Content:99.0%

Packaging:Customizable

Mitopodozide CAS NO 1508-45-8

Unit Price:Get Price

CAS No.:1508-45-8

Grade:Pharmacy Grade

Content:99.90%

Packaging:Customizable

Taxane CAS NO 1605-68-1

Unit Price:Get Price

CAS No.:1605-68-1

Grade:Pharmacy Grade

Content:99.90%

Packaging:Customizable

Trethinium Tosilate CAS NO 1748-43-2

Unit Price:Get Price

CAS No.:1748-43-2

Grade:Pharmacy Grade

Content:99.90%

Packaging:Customizable

Alkylating Antineoplastic Agents

Alkylating antineoplastic agents are cytotoxic APIs that form covalent bonds with DNA, leading to cross-linking, strand breaks, and inhibition of replication and transcription. This class includes nitrogen mustards, nitrosoureas, alkyl sulfonates, triazenes, and platinum-based drugs. They are effective against a wide range of hematologic malignancies and solid tumors such as breast cancer, ovarian cancer, sarcomas, and brain tumors. Their mechanism is cell cycle–nonspecific, making them particularly active against rapidly dividing cells. However, their strong cytotoxicity can result in bone marrow suppression, infertility, and secondary malignancies. Despite these risks, alkylating agents remain foundational drugs in many chemotherapeutic regimens due to their broad antitumor activity.

Carmustine CAS NO 154-93-8

Unit Price:Get Price

CAS No.:154-93-8

Grade:Pharmacy Grade

Content:99.00%

Packaging:Customizable

Cisplatin CAS NO 15663-27-1

Unit Price:Get Price

CAS No.:15663-27-1

Grade:Pharmacy Grade

Content:99.00%

Packaging:Customizable

Oxaliplatin CAS NO 61825-94-3

Unit Price:Get Price

CAS No.:61825-94-3

Grade:Pharmacy Grade

Content:99.00%

Packaging:Customizable

Azatepa CAS NO 125-45-1

Unit Price:Get Price

CAS No.:125-45-1

Grade:Pharmacy Grade

Content:99.0%

Packaging:Customizable

Nitromin CAS NO 126-85-2

Unit Price:Get Price

CAS No.:126-85-2

Grade:Pharmacy Grade

Content:99.0%

Packaging:Customizable

4-[[4-[Bis(2-Chloroethyl)Amino]Phenoxy]Carbonylamino]Benzoic Acid CAS NO 148-78-7

Unit Price:Get Price

CAS No.:148-78-7

Grade:Pharmacy Grade

Content:99.0%

Packaging:Customizable

Melphalan CAS NO 148-82-3

Unit Price:Get Price

CAS No.:148-82-3

Grade:Pharmacy Grade

Content:99.0%

Packaging:Customizable

Dl-Tryptophan Mustard CAS NO 153-88-8

Unit Price:Get Price

CAS No.:153-88-8

Grade:Pharmacy Grade

Content:99.0%

Packaging:Customizable

Tinib Antineoplastic Drugs

Tinib antineoplastic drugs are a major class of targeted cancer therapies that inhibit dysregulated tyrosine kinases or serine/threonine kinases involved in tumor growth, angiogenesis, and metastasis. Represented by imatinib, erlotinib, gefitinib, sunitinib, sorafenib, and numerous next-generation inhibitors, these APIs block oncogenic signaling pathways such as EGFR, VEGFR, PDGFR, BCR-ABL, ALK, and RET. Their precision targeting enables high efficacy with reduced systemic toxicity compared to traditional chemotherapy. Tinib drugs are widely used in leukemia, lung cancer, renal cancer, gastrointestinal stromal tumors, and melanoma. Resistance caused by kinase mutations has led to the development of multi-targeted and mutation-specific inhibitors, making tinibs a cornerstone of precision oncology.

Vorinostat CAS NO 149647-78-9

Unit Price:Get Price

CAS No.:149647-78-9

Grade:Pharmacy Grade

Content:99.00%

Packaging:Customizable

4,4'-Diacetyldiphenylureabis(Guanylhydrazone)Ditosylate CAS NO 15427-93-7

Unit Price:Get Price

CAS No.:15427-93-7

Grade:Pharmacy Grade

Content:99.90%

Packaging:Customizable

Bendamustine CAS NO 16506-27-7

Unit Price:Get Price

CAS No.:16506-27-7

Grade:Pharmacy Grade

Content:99.90%

Packaging:Customizable

Oxazolopyridocarbazole CAS NO 103769-63-7

Unit Price:Get Price

CAS No.:103769-63-7

Grade:Pharmacy Grade

Content:99.90%

Packaging:Customizable

V CAS NO 103956-33-8

Unit Price:Get Price

CAS No.:103956-33-8

Grade:Pharmacy Grade

Content:99.90%

Packaging:Customizable

Regelin CAS NO 109974-21-2

Unit Price:Get Price

CAS No.:109974-21-2

Grade:Pharmacy Grade

Content:99.90%

Packaging:Customizable

Regopar CAS NO 110445-23-3

Unit Price:Get Price

CAS No.:110445-23-3

Grade:Pharmacy Grade

Content:99.90%

Packaging:Customizable

Paprin CAS NO 114949-43-8

Unit Price:Get Price

CAS No.:114949-43-8

Grade:Pharmacy Grade

Content:99.90%

Packaging:Customizable

Idiopathic Pulmonary Fibrosis (IPF) Therapeutics

Idiopathic pulmonary fibrosis (IPF) therapeutics include APIs developed to slow disease progression, reduce fibrotic tissue formation, and improve respiratory function in patients with chronic and progressive lung fibrosis. Key agents include pirfenidone and nintedanib, which inhibit fibrogenic cytokines, growth factor signaling, and pathways involving TGF-β, VEGF, and PDGF. These drugs reduce fibroblast proliferation, collagen deposition, and inflammatory signaling in lung tissue. Although IPF remains incurable, these therapies significantly delay functional decline and increase quality of life. IPF therapeutics are essential for managing symptoms, reducing exacerbations, and extending survival in affected patients. Ongoing research focuses on combination regimens, antifibrotic biologics, and precision-medicine approaches.

Epiamastatin Hcl CAS NO 100992-59-4

Unit Price:Get Price

CAS No.:100992-59-4

Grade:Pharmacy Grade

Content:99.90%

Packaging:Customizable

Nintedanib CAS NO 1174335-83-1

Unit Price:Get Price

CAS No.:1174335-83-1

Grade:Pharmacy Grade

Content:99.90%

Packaging:Customizable